(Q35187795)

7 August 2017

1 reference

title

Drug therapy of diabetes in the elderly (English)

1 reference

7 August 2017

Ralph Oiknine

1

1 reference

7 August 2017

Arshag D Mooradian

series ordinal

2

1 reference

7 August 2017

language of work or name

1 reference

1 July 2003

1 reference

Biomedicine and Pharmacotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

57

1 reference

7 August 2017

issue

5-6

1 reference

7 August 2017

page(s)

231-239

1 reference

Fasting serum cholesterol and triglycerides in a ten-year prospective study in old age.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

1 reference

7 January 2021

The reliability of self blood glucose monitoring in elderly diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

A rational approach to drug therapy of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Management of obesity in the elderly: special considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Lactic acidosis in patients with diabetes treated with metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Dose-response profile of acarbose in older subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Implications of the UK prospective diabetes study: questions answered and issues remaining

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

The role of thiazolidinediones in the treatment of patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Drug therapy of non-insulin-dependent diabetes mellitus in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Diabetes mellitus in elderly nursing home patients. A survey of clinical characteristics and management

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Drug therapy of postprandial hyperglycaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

The continuing epidemics of obesity and diabetes in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Nonhypoglycemic effects of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Novel sulfonylurea and non-sulfonylurea drugs to promote the secretion of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Antecedents of death in the men of a Veterans Administration nursing home

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Incidence of lactic acidosis in metformin users

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Vitamin supplementation therapy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2803%2900052-0

7 January 2021

10.1016/S0753-3322(03)00052-0

Identifiers

DOI

1 reference

7 August 2017

1 reference